Task: Named Entity Recognition
Input (English):  Here we studied minimal residual disease ( MRD ) of patients with acute myeloid leukemia ( AML ) who have PML / RAR alpha or AML1 / ETO as well as the phenotypic analysis of lymphocyte subsets involved in antitumor immunity .
Output (English): AML1 / ETO